Increasing lines of evidence are raising the possibility that cell surface-bound, exosome-anchored, or simply free-secreted Hsp90 may serve as safer and more effective therapeutic targets than their intracellular counterparts in cancer and other inflammatory human disorders. This evidence concerns the gene HSP90AB1 and cancer.